DeepBio announced that it has been awarded the CES Innovation Award as the first Korean cancer diagnosis A.I. company in CES 2024, the world’s largest electronics exhibition, to be held in Las Vegas, USA, in the upcoming January
Through the work that we do, the team at Deciphex helps pharma to accelerate the process of essential drug development and helps patients to get timely and accurate diagnosis...
In a recent study, researchers at the Federal University of Ceará in Brazil evaluated the accuracy of digital whole slide imaging (WSI) compared to traditional light microscopy for cervical cytology screening and diagnosis.
Digital pathology includes the acquisition, management, sharing and interpretation of pathology information (including slides and data) in a digital environment (Royal College of Pathologists). One part of Digital pathology is the transition from light microscopy to Whole Slide Imaging for primary diagnosis. Awanui Laboratories has begun this process and Dunedin was selected as the pilot laboratory before rolling out across other histology departments in this network. During this assessment, there are technical (grossing, embedding etc.), information technology (IT) and pathologist challenges that need consideration. An overview of lessons learned during this process will be shared in this presentation.
In the ever-evolving healthcare landscape, tech-enabled innovation has been a game changer. This field has gained significant traction in recent years, and evidence can be seen at pathology conferences around the world. At the recent European Congress of Pathology held in my home city of Dublin, it was quite evident the push and desire to streamline and enhance the efficiency of digital pathology workflows is stronger than ever.
Roche’s navify Digital Pathology software platform now offers Ibex’s Artificial Intelligence (AI) algorithms to support clinicians in the diagnosis of breast and prostate cancer. Roche and Ibex cloud-based digital pathology and AI solutions run on Amazon Web Services (AWS), enabling a scalable and sustainable ecosystem for pathology laboratories. This collaboration builds on Roche’s Digital Pathology Open Environment on [...]
A new pathologic scoring system that accurately assesses how much lung tumor is left after a patient receives presurgical cancer treatments can be used to predict survival, according to new research led by investigators at the Bloomberg~Kimmel Institute for Cancer Immunotherapy at the Johns Hopkins Kimmel Cancer Center and the Mark Foundation Center for Advanced Genomics and Imaging at the Johns Hopkins University.
Leica Biosystems, a global leader in pathology workflow solutions, is pleased to announce the release of three important software features for its proven Aperio GT 450 Digital Pathology scanner. The announcement took place at the Society for Immunotherapy of Cancer’s annual meeting, and visitors to the Leica Biosystems booth had the opportunity to experience the new features hands-on.
Leica Biosystems and Paige are thrilled to announce their exciting collaboration, leveraging their technologies to facilitate seamless Digital Pathology adoption and advancement. Join us for this webinar to learn how together they will revolutionize the Digital Pathology lab experience by providing one simple and holistic solution that will transform the way pathologists work. Seize the opportunity to explore Leica Biosystems and Paige's transformative collaboration!
Deep Bio, a leading AI healthcare company specializing in deep learning and cancer pathology, is proud to announce its participation in the groundbreaking CancerX initiative, a public-private partnership unveiled earlier this year as part of the White House Cancer Moonshot program. This strategic partnership marks a significant milestone in the company's mission to transform the landscape of cancer diagnosis and prognosis.
